Nature Reviews Drug Discovery

Nature Reviews Drug Discovery, abbreviated Nat. Rev. Drug Discov. , Is a journal that is published by the Nature Publishing Group. The first edition appeared in January 2002. Currently ( 2012) twelve issues per year are published. The journal publishes reviews in the fields of drug discovery and drug development. The following topics are considered:

  • Discovery of target structures
  • Rational drug design
  • Combinatorial and parallel synthesis
  • Medicinal Chemistry
  • Classes of key compounds
  • Natural Products
  • High -throughput screening
  • Novel therapeutic approaches for disease states
  • Microarrays
  • Bioinformatics
  • Absorption, distribution, metabolism and elimination
  • Pharmacokinetics and pharmacodynamics
  • Pharmacology
  • Toxicology
  • Pharmacogenomics and toxicogenomics
  • Drug release
  • Biotechnology
  • Vaccines
  • Analysis of clinical trials
  • Regulatory things
  • Pharmacoeconomics

The impact factor of the journal was in 2012 at 33.078. According to the statistics of the ISI Web of Knowledge, the Journal with this impact factor in the category Biotechnology and Applied Microbiology is conducted in the first place of 159 magazines and in the category of pharmacology and pharmacy in the first place of 260 magazines.

Chief Editor is Peter Kirkpatrick, who is employed by the publisher.

Biotransformation Regulation of therapeutic goods Web of Science
592946
de